CNX Financial Statements & Analysis
Complete financial statements for CNX including income statement, balance sheet, and cash flow statement. Analyze CNX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
48.9% ↑
Net Income
799.7% ↑
Gross Margin
64.3% ↑
Operating Margin
212.4% ↑
Balance Sheet
Current Ratio
32.1% ↑
Debt to Equity
1.1% ↓
Asset Turnover
39.3% ↑
Cash Flow
Operating Cash Flow
26.1% ↑
Net Cash Flow
-176.2% ↓
Free Cash Flow
93.9% ↑
Cash Flow to Debt
17.9% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 1.44B | 2.14B | 48.9% | |
| Gross Profit | 413.77M | 1.01B | 144.6% | |
| Operating Income | 169.32M | 787.48M | 365.1% | |
| Net Income | -90.49M | 633.16M | 799.7% | |
| EPS | -0.60 | 4.48 | 846.7% | |
| EBITDA | 515.99M | 1.55B | 199.9% | |
| Gross Margin | 28.75% | 47.23% | 64.3% | |
| Operating Margin | 11.77% | 36.76% | 212.4% | |
| Net Income Margin | -6.29% | 29.55% | 570.0% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.14B | 1.44B | 1.51B | — | — |
| Gross Profit | 1.01B | 413.77M | 529.57M | — | — |
| Operating Income | 787.48M | 169.32M | 314.19M | — | — |
| Net Income | 633.16M | -90.49M | 1.72B | — | — |
| EPS | 4.48 | -0.60 | 10.63 | — | — |
| EBITDA | 1.55B | 515.99M | 2.80B | — | — |
| Gross Margin | 47.23% | 28.75% | 35.16% | — | — |
| Operating Margin | 36.76% | 11.77% | 20.86% | — | — |
| Net Income Margin | 29.55% | -6.29% | 114.23% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into CNX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics